Mark Auerbach, Director at RCS Capital, holds 0.00 shares in Pardes Biosciences (Ticker: PRDS), holds 112.04K shares in RCS Capital (Ticker: RCAPQ), holds 0.00 shares in Optimer Pharma (Ticker: OPTR).

See the Hottest Stocks Based on Insider Trading >

Mark Auerbach
RCS Capital (RCAPQ)
Director

Not Ranked

Mark Auerbach has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

Mark Auerbach does not currently own shares as a corporate insider.

A breakdown of Mark Auerbach's holdings

See the Top Stocks by Insiders

Insider Roles

Assembly Biosciences
(ASMB)

Director

Roles that Mark Auerbach holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

RCS Capital
(RCAPQ)

Rating:Informative Buy

Date:Jun 09, 2014 - Jun 09, 2015

Return:-61.70%

The most profitable trade made by Mark Auerbach

See the Latest Stocks Traded by Insiders

Mark Auerbach's Trading History

RCAPQ

RCS Capital

Dec 28, 2015

―

Uninformative Sell

229.47K

$560.20

PRDS

Pardes Biosciences

Aug 31, 2023

―

Uninformative Sell

―

$0.00

OPTR

Optimer Pharma

―

PRX

Par Pharmaceutical Cos. Inc.

―

ASMB

Assembly Biosciences

―

Director

―

$0.00

List of latest transactions for each holding click on a transaction to see Mark Auerbach's performance on stock

See All Insider Trading from Today

Mark Auerbach insider profile FAQ

What is the percentage of profitable transactions made by Mark Auerbach?

The percentage of profitable transactions made by Mark Auerbach is ―.

What is the average return per transaction made by Mark Auerbach?

The average return per transaction made by Mark Auerbach is ―.

What stocks does Mark Auerbach hold?

Mark Auerbach holds: RCAPQ, PRDS, OPTR, PRX, ASMB stocks.

What was Mark Auerbach’s latest transaction?

Mark Auerbach latest transaction was an Uninformative Sell of ―.

What was Mark Auerbach's most profitable transaction?

Mark Auerbach’s most profitable transaction was an Informative Buy of RCAPQ stock on June 9, 2014. The return on the trade was -61.70%.

What is Mark Auerbach's role in RCS Capital?

Mark Auerbach's role in RCS Capital is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Mark Auerbach Insider Profile

Mark Auerbach RCS Capital (RCAPQ)Director